OMEROS

Serial Number 77086751
606

Registration Progress

Application Filed
Jan 19, 2007
Under Examination
Oct 2, 2007
Approved for Publication
Jun 20, 2007
Published for Opposition
Jul 10, 2007
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: OMEROS
Previous Owner: OMEROS CORPORATION
Classes: 005

Trademark Image

OMEROS

Basic Information

Serial Number
77086751
Filing Date
January 19, 2007
Published for Opposition
July 10, 2007
Abandonment Date
November 1, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 1, 2010
Classes
005

Rights Holder

OMEROS CORPORATION

03
Address
Attn: Marcia S. Kelbon
1420 Fifth Avenue, Suite 2600
Seattle, WA 98101

Ownership History

OMEROS CORPORATION

Original Applicant
03
Seattle, WA

OMEROS CORPORATION

Owner at Publication
03
Seattle, WA

Legal Representation

Attorney
Marcia S. Kelbon

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

32 events
Date Code Type Description Documents
Nov 1, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Nov 1, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 3, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 2, 2010 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 1, 2010 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 1, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 2, 2009 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 21, 2009 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 2, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 21, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 1, 2009 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 1, 2009 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 1, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 25, 2008 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 25, 2008 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 25, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 14, 2008 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 1, 2008 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 1, 2008 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 2, 2007 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 10, 2007 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 20, 2007 NPUB O NOTICE OF PUBLICATION Loading...
Jun 1, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 1, 2007 ALIE A ASSIGNED TO LIE Loading...
May 14, 2007 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 14, 2007 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 14, 2007 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 14, 2007 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 9, 2007 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 9, 2007 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 8, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 24, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely -- surgical compositions containing pharmacologic agents for the inhibition of pain, inflammation, cartilage loss, smooth muscle spasm and/or cell adhesion, for promoting mydriasis and/or for controlling intraocular pressure associated with surgical, diagnostic, therapeutic or medical procedures and other trauma; chondroprotective compositions containing pharmacologic agents for the treatment or inhibition of cartilage loss, pain and/or inflammation; pharmacologic agents and antibodies for the inhibition of the complement immune system; pharmacological agents for the treatment of schizophrenia and other psychiatric disorders; pharmacological agents for the treatment of Parkinson's disease and other neuromuscular and neurodegenerative disorders; pharmacological agents for the treatment of obesity and other metabolic disorders; pharmacological agents for the treatment or inhibition of pain; pharmacological agents for the treatment of sleep and attention deficit disorders; and drug delivery systems, namely pharmacologic agents or antibodies carried in a hydrogel or micellular delivery vehicle
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The English translation of the word OMEROS in the mark is HOMER.

Classification

International Classes
005